Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours Β· Estimated delivery Sep 4 - Sep 9
~ AlphaMD Jake was staring at the ceiling again at 3 a.m., wired and exhausted at the same time, wondering if starting TRT was worth it if he never slept again
Un enfoque adecuado busca: Perder grasa Mantener msculo Evitar dficits nutricionales Mejorar la energa y el bienestar Optimizar la salud metablica No se trata solo de comer menos, sino de nutrirse mejor
Peptides for Enhanced Vitality and Health Beyond weight loss, peptides can dramatically enhance your quality of life, targeting anti-aging, muscle growth, brain health, gut health, and overall vitality
GLP-1 7-36 is a 30 amino acid peptide derived from the proglucagon molecule that is synthesised in intestinal L cells, as well as in alpha cells of the pancreas and in neuronal clusters of the central nervous system (CNS).2 It is a peptide with a short half-life (23 min), due to rapid renal clearance and degradation by the enzyme dipeptidyl peptidase-4 (DPP-4), which converts GLP-1 into GLP-1 9-36, a form that does not interact with the GLP-1 receptor.1 The GLP-1 receptor (GLP-1R) belongs to the class B G protein-coupled glucagon receptor family.2,3 Activation of the Gs subunit leads to stimulation of adenylate cyclase, synthesis of cyclic AMP, mobilisation of intracellular calcium, and glucose-dependent insulin release by pancreatic beta cells.2,3 Intracellular signalling also involves various additional pathways, such as recruitment of beta-arrestin-1, which modulates receptor internalisation and desensitisation, as well as the effects of certain GLP-1R agonists.3,4 Depending on the structure of the ligand, intracellular signalling pathways are modulated towards cyclic AMP generation, activation of kinase cascades (ERK), and beta-arrestin-1 recruitment, all of which influence the biological effect and desensitisation of the GLP-1 receptor.4 Some GLP-1R agonists exhibit biased agonism, favouring intracellular activation of cyclic AMP with reduced beta-arrestin recruitment, which results in less GLP-1R desensitisation and a more prolonged biological action (Table 1)
